NEOS Investment Management LLC Purchases 9,403 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

NEOS Investment Management LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 24.1% in the fourth quarter, HoldingsChannel reports. The fund owned 48,357 shares of the healthcare conglomerate’s stock after purchasing an additional 9,403 shares during the quarter. UnitedHealth Group makes up 0.6% of NEOS Investment Management LLC’s portfolio, making the stock its 27th largest position. NEOS Investment Management LLC’s holdings in UnitedHealth Group were worth $24,462,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. NewSquare Capital LLC purchased a new stake in UnitedHealth Group during the 4th quarter worth approximately $25,000. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $30,000. Promus Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter worth $32,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group in the third quarter valued at about $37,000. Finally, Pillar Financial Advisors LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $40,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Stock Up 0.9 %

Shares of UNH opened at $518.10 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The firm has a market cap of $473.92 billion, a P/E ratio of 33.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company’s 50-day moving average price is $508.60 and its 200 day moving average price is $545.37. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the firm earned $5.83 EPS. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.62%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

Wall Street Analyst Weigh In

Several analysts have commented on UNH shares. Stephens lifted their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research report on Friday, January 10th. Finally, KeyCorp reissued an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.